ORGO missed EPS expectations by 73.01%
Aug 08, 2025, 10:32 AM
0.00%
What does ORGO do
Organogenesis Holdings, a regenerative medical company based in Canton, Massachusetts, specializes in advanced wound care and surgical products, employing 862 staff since its IPO on December 2, 2016. Their portfolio includes Apligraf, Dermagraft, and various placental allografts for treating wounds and soft tissue repairs.
Organogenesis Holdings (ORGO) reported a negative EPS surprise in its most recent quarterly earnings. For the most recent quarter, Organogenesis Holdings's actual EPS was -$0.10, missing the estimate of -$0.06 per share, resulting in a -73.01% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.